nicolas widmer (12 Ergebnisse)

Soft cover. Zustand: Very Good. 36 pages. Kingsley Widmer "The limits of Pacifism" / Colin Johnson "The fallacy of non-violent defence" / Nicolas and Ruth Walter "The Committee of 100 and anarchism" / Francis Ellingham "Automation & individualism" / Bosco Nedelcovic "Automation and work" (SL#122).

Soft cover. Zustand: Very Good. 36 pages. Kingsley Widmer "The limits of Pacifism" / Colin Johnson "The fallacy of non-violent defence" / Nicolas and Ruth Walter "The Committee of 100 and anarchism" / Francis Ellingham "Automation & Individualism" / Bosco Nedelcovic" (SL#111).

Softcover (Saddle-stapled). Zustand: Very Good. Zustand des Schutzumschlags: No Dust Jacket. First Edition. Staples rusted. Slight wear and slight soiling to spine, cover and corners. ; With printed wrappers. ; 13.8x21.5x0.3 cm; (161-192) pages.

Zustand: New. pp. 248.

Taschenbuch. Zustand: Neu. Imatinib plasma concentrations variability in oncologic patients | Is imatinib a candidate drug for a therapeutic drug monitoring program? | Nicolas Widmer | Taschenbuch | 248 S. | Englisch | 2010 | LAP LAMBERT Academic Publishing | EAN 9783838385112 | Verantwortliche Person für die EU: BoD - Books on Demand, In de Tarpen 42, 22848 Norderstedt, info[at]bod[dot]de | Anbieter: preigu.

Editions CRAterre 1989. 177 pages. Broché. Bon état. Avec des illustrations en noir et blanc.

Taschenbuch. Zustand: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -The anticancer drug imatinib has transformed the treatment and prognosis of chronic myeloid leukemia and gastrointestinal stromal tumor. However, the treatment must be taken indefinitely and is not devoid of inconveniences and toxicity. Moreover, resistance or escape from disease control are occurring. Considering the large interindividual differences in the function of the enzymatic and transport systems involved in imatinib disposition, exposure to this drug can be expected to vary widely among patients. This book describes an observational clinical trial aiming at exploring the influence of these covariates on imatinib pharmacokinetics and assessing the interindividual variability of the pharmacokinetic parameters of the drug. A large interindividual variability was observed, together with some preliminary concentration-effect relationships. These elements are arguments to further investigate the potential benefit of a therapeutic drug monitoring program to optimize the use of imatinib in patients. Such results should be especially useful to clinical oncologists or scientists involved in clinical oncology research. 248 pp. Englisch.

Zustand: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Widmer Nicolasis a Swiss pharmacist who specialized both in Hospital Pharmacy and Clinical Pharmacology, and gained his PhD in Life Sciences in 2006. He is at present in charge of the Therapeutic Drug Monitoring service at the Div.

Zustand: New. Print on Demand pp. 248 2:B&W 6 x 9 in or 229 x 152 mm Perfect Bound on Creme w/Gloss Lam.

Zustand: New. PRINT ON DEMAND pp. 248.

Taschenbuch. Zustand: Neu. This item is printed on demand - Print on Demand Titel. Neuware -The anticancer drug imatinib has transformed the treatment and prognosis of chronic myeloid leukemia and gastrointestinal stromal tumor. However, the treatment must be taken indefinitely and is not devoid of inconveniences and toxicity. Moreover, resistance or escape from disease control are occurring. Considering the large interindividual differences in the function of the enzymatic and transport systems involved in imatinib disposition, exposure to this drug can be expected to vary widely among patients. This book describes an observational clinical trial aiming at exploring the influence of these covariates on imatinib pharmacokinetics and assessing the interindividual variability of the pharmacokinetic parameters of the drug. A large interindividual variability was observed, together with some preliminary concentration-effect relationships. These elements are arguments to further investigate the potential benefit of a therapeutic drug monitoring program to optimize the use of imatinib in patients. Such results should be especially useful to clinical oncologists or scientists involved in clinical oncology research.VDM Verlag, Dudweiler Landstraße 99, 66123 Saarbrücken 248 pp. Englisch.

Taschenbuch. Zustand: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - The anticancer drug imatinib has transformed the treatment and prognosis of chronic myeloid leukemia and gastrointestinal stromal tumor. However, the treatment must be taken indefinitely and is not devoid of inconveniences and toxicity. Moreover, resistance or escape from disease control are occurring. Considering the large interindividual differences in the function of the enzymatic and transport systems involved in imatinib disposition, exposure to this drug can be expected to vary widely among patients. This book describes an observational clinical trial aiming at exploring the influence of these covariates on imatinib pharmacokinetics and assessing the interindividual variability of the pharmacokinetic parameters of the drug. A large interindividual variability was observed, together with some preliminary concentration-effect relationships. These elements are arguments to further investigate the potential benefit of a therapeutic drug monitoring program to optimize the use of imatinib in patients. Such results should be especially useful to clinical oncologists or scientists involved in clinical oncology research.